MCT4 and MCT2 are involved in the transfer of lactate from astrocytes to neurons in the brain, and MCTs in the central nervous system may show impaired expression in AD 66-69; thus, modulating their expression levels represents a potential strategy for neuroprotection 70, 71. This evidence concerns the gene SLC16A7 and Alzheimer disease.